Clinical Trial Update: UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 study evaluating UV1 vaccine in combination with pembrolizumab for unresectable or metastatic malig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• UV1 vaccine (UV1 vaccine)

Snippet

Sponsor: Ultimovacs ASA | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED